These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1603880)

  • 21. Serotoninergic dysfunction in bipolar disorder.
    Marazziti D; Lenzi A; Cassano GB
    Pharmacopsychiatry; 1991 Sep; 24(5):164-7. PubMed ID: 1775521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet abnormalities in aggressive subjects with mental deficiency.
    Marazziti D; Palego L; Silvestri S; Presta S; Balestri C; Batistini A; Conti L
    J Psychiatry Neurosci; 1996 Mar; 21(2):109-13. PubMed ID: 8820176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
    Charney DS; Goodman WK; Price LH; Woods SW; Rasmussen SA; Heninger GR
    Arch Gen Psychiatry; 1988 Feb; 45(2):177-85. PubMed ID: 3337615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL; Zohar J; Benkelfat C; Pato MT; Pigott TA; Insel TR
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls.
    Lesch KP; Hoh A; Disselkamp-Tietze J; Wiesmann M; Osterheider M; Schulte HM
    Arch Gen Psychiatry; 1991 Jun; 48(6):540-7. PubMed ID: 1674853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonergic probes in obsessive compulsive disorder.
    Zohar J; Kindler S
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():39-40. PubMed ID: 1517556
    [No Abstract]   [Full Text] [Related]  

  • 28. Buspirone induced prolactin responses in obsessive-compulsive disorder (OCD): is OCD a 5-HT2 receptor disorder?
    Lucey JV; Butcher G; Clare AW; Dinan TG
    Int Clin Psychopharmacol; 1992; 7(1):45-9. PubMed ID: 1624756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder.
    Goodman WK; McDougle CJ; Price LH
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():35-8. PubMed ID: 1517555
    [No Abstract]   [Full Text] [Related]  

  • 30. Methodological issues in the preparation and assay of platelet 3H-imipramine binding.
    Severson JA; Schneider LS; Fredrickson ER
    Psychiatry Res; 1990 Jul; 33(1):19-29. PubMed ID: 1699244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet monoamine oxidase activity in obsessive-compulsive disorder.
    Arrojo M; Baca-Garcia E; Perez-Rodriguez MM; Dolengevich-Segal H; Navio-Acosta M; Rodriguez-Salgado B; Saiz-Ruiz J
    Eur Psychiatry; 2007 Nov; 22(8):525-9. PubMed ID: 17761404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet serotonergic markers and aggressive behaviour in healthy subjects.
    Castrogiovanni P; Capone MR; Maremmani I; Marazziti D
    Neuropsychobiology; 1994; 29(3):105-7. PubMed ID: 8022528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loudness dependence of auditory evoked potentials in obsessive-compulsive disorder: a pilot study.
    Carrillo-de-la-Peña MT; Mavrogiorgou P; Juckel G; Hauke W; Gallinat J; Frodl T; Zaudig M; Hegerl U
    Psychiatry Res; 2000 Apr; 93(3):209-16. PubMed ID: 10760379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neurobiology of obsessive-compulsive disorder].
    Karch S; Pogarell O
    Nervenarzt; 2011 Mar; 82(3):299-307. PubMed ID: 21424418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder.
    Nelson EC; Sheline YI; Bardgett ME; Jackson JL; Csernansky JG
    Psychiatry Res; 1995 Sep; 58(2):117-25. PubMed ID: 8570763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between the serotonin and dopamine systems in humans: preliminary findings.
    Castrogiovanni P; Di Muro A; Maremmani I; Perossini M; Marazziti D
    Brain Res; 1989 Dec; 504(1):129-31. PubMed ID: 2598007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of imipramine and trazodone on the re-uptake of (3H) serotonin by thrombocytes in patients with endogenous depression: changes in antidepressive therapy].
    Katasonow AB; Brusow OS; Beljaew BS; Slobina GP; Faktor MI; Larionowa TB; Trunte K; Lidemann RR
    Psychiatr Neurol Med Psychol (Leipz); 1989 Apr; 41(4):210-7. PubMed ID: 2544916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine.
    Hanna GL; McCracken JT; Cantwell DP
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):173-8. PubMed ID: 2016218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder.
    Austin LS; Lydiard RB; Ballenger JC; Cohen BM; Laraia MT; Zealberg JJ; Fossey MD; Ellinwood EH
    Biol Psychiatry; 1991 Aug; 30(3):225-32. PubMed ID: 1832972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unveiling serotonergic dysfunction of obsessive-compulsive disorder on prefrontal network dynamics: a computational perspective.
    Yin L; Yu Y; Han F; Wang Q
    Cereb Cortex; 2024 Jun; 34(6):. PubMed ID: 38904079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.